Bid target Shire reports 6 pct rise in first-quarter earnings
LONDON, April 26 (Reuters) - Shire, the London-listed drugmaker targeted by Takeda Pharmaceutical, reported a 6 percent rise in first-quarter earnings on Thursday, helped by higher product sales a
Read more